BOSTON--(BUSINESS WIRE)--Emulate, Inc., the leading provider of next-generation Organ-on-a-Chip technology, in partnership with FUJIFILM Cellular Dynamics, Inc., a pioneering global developer and ...
BOSTON--(BUSINESS WIRE)--Emulate, Inc., the leading provider of next-generation in vitro Organ-Chip models, today announced the release of its new Chip-R1™ Rigid Chip, designed to minimize drug ...
Historical data indicate that animal models are not ideal for the determination of the efficacy and safety of human therapeutics. Ninety percent of drugs that pass animal studies do not receive ...
Since 2022, the Food and Drug Administration has been on a journey to reduce the reliance on animal testing in drug development. The reasons are manifold, according to the agency: improving drug ...
Researchers are increasingly turning to organ-on-a-chip technology for drug testing and other applications. In a clean room in his lab, Sean Moore peers through a microscope at a bit of intestine, its ...
insights from industryJim CorbettCEOEmulate, Inc. In this interview, NewsMedical speaks with Jim Corbett, CEO of Emulate, Inc., about the development and impact of the AVA Emulation System and how it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results